Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement

Eur Heart J. 2015 Dec 7;36(46):3227-37. doi: 10.1093/eurheartj/ehv162. Epub 2015 Jul 27.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Anti-Arrhythmia Agents / therapeutic use
  • Arrhythmogenic Right Ventricular Dysplasia / therapy*
  • Catheter Ablation / methods
  • Consensus
  • Defibrillators, Implantable
  • Electrophysiologic Techniques, Cardiac / methods
  • Fibrinolytic Agents / therapeutic use
  • Heart Failure / etiology
  • Heart Transplantation / methods
  • Humans
  • Long-Term Care
  • Practice Guidelines as Topic
  • Risk Assessment / methods
  • Risk Reduction Behavior

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents
  • Fibrinolytic Agents